DK1206268T3 - Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse - Google Patents

Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse

Info

Publication number
DK1206268T3
DK1206268T3 DK00954693T DK00954693T DK1206268T3 DK 1206268 T3 DK1206268 T3 DK 1206268T3 DK 00954693 T DK00954693 T DK 00954693T DK 00954693 T DK00954693 T DK 00954693T DK 1206268 T3 DK1206268 T3 DK 1206268T3
Authority
DK
Denmark
Prior art keywords
biologically active
active agent
preparation
release
compositions
Prior art date
Application number
DK00954693T
Other languages
English (en)
Inventor
Manja Ahola
Eija Saeilynoja
Jukka Salonen
Antti Yli-Urpo
Risto Penttinen
Original Assignee
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxid Oy filed Critical Bioxid Oy
Application granted granted Critical
Publication of DK1206268T3 publication Critical patent/DK1206268T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK00954693T 1999-08-25 2000-08-22 Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse DK1206268T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI991806A FI19991806A (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
PCT/FI2000/000710 WO2001013924A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
EP00954693A EP1206268B1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof

Publications (1)

Publication Number Publication Date
DK1206268T3 true DK1206268T3 (da) 2005-01-10

Family

ID=8555195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954693T DK1206268T3 (da) 1999-08-25 2000-08-22 Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse

Country Status (11)

Country Link
US (1) US7112339B1 (da)
EP (1) EP1206268B1 (da)
JP (1) JP2003507427A (da)
AT (1) ATE279928T1 (da)
AU (1) AU6705400A (da)
CA (1) CA2379982A1 (da)
DE (1) DE60015151T2 (da)
DK (1) DK1206268T3 (da)
ES (1) ES2230141T3 (da)
FI (1) FI19991806A (da)
WO (1) WO2001013924A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
CA2442284C (en) 2001-04-04 2009-10-06 Delsitech Oy Biodegradable carrier and method for preparation thereof
ATE466281T1 (de) * 2002-05-07 2010-05-15 Univ New York State Res Found ßHIGH THROUGPUTß METHODE, UM BIOMOLEKÜLANLIEFERUNG FORMULIERUNGEN ZU KENNZEICHNEN
DE10249874A1 (de) * 2002-10-25 2004-05-06 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Antiadhäsive Beschichtung zur Ausrüstung von Wundverbänden
US7923030B2 (en) 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
WO2005009604A1 (en) 2003-07-31 2005-02-03 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
DK1718564T3 (da) * 2004-02-27 2019-01-21 Delsitech Oy Fremgangsmåde til regulerbar fremstilling af bioresorberbar sol-gel afledt sio2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
EP2431088A1 (en) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
KR101070345B1 (ko) 2009-07-03 2011-10-06 서울대학교산학협력단 생체활성인자가 포함된 유무기 혼성 복합 코팅층, 생체 이식용 임플란트 및 그 제조방법
MX2012003321A (es) * 2011-03-18 2013-03-21 Int Flavors & Fragrances Inc Microcapsulas producidas a partir de precursores de sol-gel mezclados y metodos para producir las mismas.
US9205150B2 (en) * 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JP3488965B2 (ja) * 1996-05-21 2004-01-19 日本山村硝子株式会社 ゾル−ゲル法による独立膜の製造方法
SK284193B6 (sk) * 1996-05-29 2004-10-05 Delsitech Oy Prostriedok na podávanie biologicky účinnej látky, zabezpečujúci jej pomalé uvoľňovanie, jeho použitie a farmaceutický prostriedok s jeho obsahom
ES2290013T3 (es) 1999-02-22 2008-02-16 Delsitech Oy Fibras de ceramica biodegradables procedentes de soles de silice.

Also Published As

Publication number Publication date
US7112339B1 (en) 2006-09-26
DE60015151D1 (de) 2004-11-25
FI19991806A (fi) 2001-02-26
DE60015151T2 (de) 2006-02-16
WO2001013924A1 (en) 2001-03-01
EP1206268A1 (en) 2002-05-22
ES2230141T3 (es) 2005-05-01
CA2379982A1 (en) 2001-03-01
EP1206268B1 (en) 2004-10-20
ATE279928T1 (de) 2004-11-15
WO2001013924A8 (en) 2001-11-01
AU6705400A (en) 2001-03-19
JP2003507427A (ja) 2003-02-25

Similar Documents

Publication Publication Date Title
DK1206268T3 (da) Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
DE59906975D1 (de) Wässrige reaktive spachtelmassen (i)
NO20000011L (no) Skumdempersammensetninger og fremgangsmÕter
DK1384478T3 (da) Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
EP1208129A1 (en) DERIVATIVE POLYURETHANE COMPOSITIONS AND THEIR METHODS OF MANUFACTURING
TW200500071A (en) Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
DK1519993T3 (da) Stuetemperatur hærdelige organopolysiloxansammensætninger
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
ID30238A (id) Komposisi-komposisi amifostin amorf yang stabil dan metode-metode untuk pembuatan dan penggunaannya
WO2003051886A8 (en) Pyrazolopyridazine derivatives
WO2003017990A3 (en) Ophthalmic composition comprising an ascomycin
EP1055720A3 (en) Compositions for stabilizing oxygen-labile species
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
PL331322A1 (en) Application of new glass compositions for making glass dental pillars and supporting pillars and method iof making such glass pillars
MXPA04003755A (es) Endoprotesis vasculares.
WO2003057149A3 (en) 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
MXPA02011321A (es) Composiciones para la agricultura que emplean organosiloxanos que contienen grupos polihidricos.
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ATE270684T1 (de) Modifizierte gruppen enthaltendes organosiloxan in pestizidzusammensetzungen
DE60201074D1 (en) Pyrazolopyridinderivate
DK1459751T3 (da) (S,S)reboxetin til behandling af migrænehovedpine
ATE339420T1 (de) Neue verbindungen
ATE302223T1 (de) Isocyanato-oligourethane
MXPA00005438A (es) Composiciones para estabilizar especies labiles al oxigeno.